GSK3B and Alzheimer disease: Fuster-Matanzo et al. identified that overexpression of glycogen synthase kinase-3β (GSK-3β), an enzyme involved in both AD pathogenesis and neurodevelopment, leads to significant decrease in the number of granular neurons and increased astrocytosis in mice DG (Fuster-Matanzo et al., 2011).